Cargando…
Prognostic Factor and Clinical Outcome in Stage III Non–Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population
PURPOSE: The optimal treatment for patients with stage III non–small cell lung cancer (NSCLC) remains controversial. This study aimed to investigate prognostic factors and clinical outcome in stage III NSCLC using real-world clinical data in the Korean population. MATERIALS AND METHODS: Among 8,110...
Autores principales: | Kim, Ho Cheol, Ji, Wonjun, Lee, Jae Cheol, Kim, Hyeong Ryul, Song, Si Yeol, Choi, Chang-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524024/ https://www.ncbi.nlm.nih.gov/pubmed/33592139 http://dx.doi.org/10.4143/crt.2020.1350 |
Ejemplares similares
-
Sex differences in the characteristics and survival of patients with non‐small‐cell lung cancer: A retrospective analytical study based on real‐world clinical data of the Korean population
por: Jeon, Da Som, et al.
Publicado: (2022) -
Frequency and clinical features of BRAF mutations among patients with stage III/IV lung adenocarcinoma without EGFR/ALK aberrations
por: Kim, Ho Cheol, et al.
Publicado: (2019) -
Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective study
por: Choi, Myeong Geun, et al.
Publicado: (2021) -
Mobile Health Management Platform–Based Pulmonary Rehabilitation for Patients With Non–Small Cell Lung Cancer: Prospective Clinical Trial
por: Ji, Wonjun, et al.
Publicado: (2019) -
Awareness and Use of Complementary and Alternative Medicine in Korean Lung Cancer Patients
por: Choi, Joon Young, et al.
Publicado: (2021)